Sun Pharma share price today: ₹1,761.00 at the close on Thursday, 29 October 2026, up ₹3.50 (+0.20%) from the previous close of ₹1,757.50. Sun Pharmaceutical Industries (NSE: SUNPHARMA) traded between ₹1,752.70 and ₹1,771.50 that day, on 11.08 lakh shares.
Sun Pharma support and resistance: the nearest support is ₹1,755.45 and the nearest resistance ₹1,766.70 on the 15-minute chart. Sun Pharma 52-week high and low: ₹2,046.90 and ₹1,583.70; it closed 14.0% below that high and 11.2% above that low.
The chart above is live while NSE trades (9:15 am to 3:30 pm IST, Monday to Friday): candles from 1 minute to daily, 10 years of daily history and 140+ indicators and studies, free to open with no account.
At the close on Thursday, 29 October 2026
Prices from NSE. The chart above streams them live while the market is open.
The near levels: the ones the chart's Auto Support & Resistance overlay draws on Sun Pharma's 15-minute chart, nearest first, below and above the price at the close, ₹1,761.00. They come from the last 30 days of 15-minute candles (30 Sept to 29 Oct). A level is a price where the share's swings turned before; the more turns, the more established it is. Each level is the middle of the narrow band where its swings turned, so it can sit slightly above or below a day's exact high or low.
Nearest: ₹1,755.45 (2 turns, the latest at 1:15 pm on 29 Oct)
Next: ₹1,751.35 (4 turns, the latest at 9:15 am on 29 Oct)
Nearest: ₹1,766.70 (5 turns, the latest at 3:00 pm on 27 Oct)
Next: ₹1,770.20 (4 turns, the latest at 10:30 am on 29 Oct)
Levels describe where the price reacted before. They are not a forecast or a recommendation, and the price can move straight through them. On the chart above, pick 15m and switch on Overlays → Auto Support & Resistance (free with an account) to see them drawn; on any other timeframe it draws that timeframe's own levels.
How far Sun Pharma's price at the close (₹1,761.00) is from its close a week, a month, 3 months and 6 months earlier, and from its 52-week high and low. Price change only: dividends are not added back.
High ₹2,046.90, on 31 Jul 2026: the price closed 14.0% below it.
Low ₹1,583.70, on 29 Jan 2026: the price closed 11.2% above it.
Prices stream as Sun Pharma trades on NSE, from 9:15 am to 3:30 pm IST, and the newest candle forms as you watch. Outside market hours the chart shows the last session, ending at its close.
Candles from 1 minute to daily — 1, 3, 5, 10, 15 and 30 minutes, 1 to 4 hours, and daily — with 10 years of daily history to scroll back through, as candles, bars, line or Heikin Ashi.
140+ indicators and studies (moving averages, RSI, MACD, Bollinger Bands, VWAP, Supertrend, volume profile and more), drawing tools and symbol compare. Opening the chart needs no account; a second indicator, the overlays such as Auto Support & Resistance, price alerts and Alpha AI need a free account.
Price, open, high, low, previous close and volume: NSE, at the 29 Oct close.
52-week high and low: NSE's own figures.
Market cap, PE and price to book: Sun Pharma's filed results (consolidated) at the price above, the same figures as Sun Pharma's financials page.
Support and resistance: Alphave's Auto Support & Resistance on 15-minute candles, 30 Sept to 29 Oct.
Delivery and the 20-day average volume: NSE's daily delivery and volume data.
Price history: closing prices from Alphave's daily NSE candles.
Alphave is run by its founder, Amit Meena. If a figure here looks wrong, email [email protected] and it will be checked and corrected.
Sun Pharmaceutical Industries is India's largest pharmaceutical company, spanning branded generics in India (the largest domestic formulations franchise), US generics (including subsidiary Taro), emerging markets, and APIs. Its key differentiator is a global specialty portfolio — dermatology and ophthalmology brands such as Ilumya, Winlevi, Cequa and Odomzo — which drives an increasing share of revenue and R&D spend. Growth drivers are the specialty ramp-up, Indian chronic-therapy leadership and select complex generics.
It is India's largest pharma company by revenue and market cap and the leader in the domestic prescription market.
Sun Pharma share price today: ₹1,761.00 at the close on Thursday, 29 October 2026, up ₹3.50 (+0.20%) from the previous close of ₹1,757.50. Sun Pharmaceutical Industries (NSE: SUNPHARMA) traded between ₹1,752.70 and ₹1,771.50 that day, on 11.08 lakh shares. NSE trades again from 9:15 am IST on the next trading day.
On the 15-minute chart (the last 30 days of 15-minute candles, to 29 Oct), against the price of ₹1,761.00 at the close, Sun Pharma has support at ₹1,755.45 (2 turns, the latest at 1:15 pm on 29 Oct) and ₹1,751.35 (4 turns, the latest at 9:15 am on 29 Oct), and resistance at ₹1,766.70 (5 turns, the latest at 3:00 pm on 27 Oct) and ₹1,770.20 (4 turns, the latest at 10:30 am on 29 Oct). These are prices where the share turned before, not a forecast. The chart's Auto Support & Resistance overlay draws them, and every other timeframe's own levels.
At the top of this page. The Sun Pharma (NSE: SUNPHARMA) chart is live while NSE trades, from 9:15 am to 3:30 pm IST, with candles from 1 minute to daily, 10 years of daily history and 140+ indicators, and it opens free with no account.
Sun Pharma's 52-week high is ₹2,046.90 (31 Jul 2026) and its 52-week low ₹1,583.70 (29 Jan 2026). At the 29 Oct close of ₹1,761.00, it is 14.0% below the high and 11.2% above the low.
Sun Pharma's market capitalisation is ₹4,22,517 crore at the 29 Oct close (239.93 crore shares at ₹1,761.00 each), and its PE ratio 34.9 on consolidated net profit attributable to shareholders over the last four quarters (Q2 FY26 to Q1 FY27), or 36.8 on FY26 profit; its price to book is 5.06. Its next results are due on 30 October 2026, and the PE will change with them. The figures behind them are on Sun Pharma's financials page.
At the 29 Oct close (₹1,761.00), Sun Pharma is +0.17% over 1 week, −5.58% over 1 month, −11.50% over 3 months and −1.00% over 6 months, on price alone. The chart above has 10 years of daily history.
SUNPHARMA (ISIN INE044A01036). It is part of the Nifty 50, Sensex, Nifty 100, Nifty 200 and Nifty 500. Sector: Pharma & Health, Pharma.
No. This page and the chart show market data for information only. They are not a recommendation to buy or sell any security.
Prices from NSE, at the 29 Oct close. Market data for information only, not a recommendation to buy or sell.